VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Sawyers Accepts his "Giants of Cancer Care" Award

Charles L. Sawyers, MD
Published: Thursday, Nov 21, 2013

Charles L. Sawyers, MD, Chair, Human Oncology and Pathogenesis Program; Marie-Josee and Henry R. Kravis Chair, Memorial Sloan-Kettering Cancer Center, accepts the Giants of Cancer Care Award for his work in prostate cancer.

Sawyers says receiving the award was a complete surprise and he is both excited and honored to be in the company of the other recipients of the award.

Sawyers played a key role in the development of imatinib (Gleevec) and dasatinib (Sprycel), two drugs that together have transformed chronic myelogenous leukemia from a fatal cancer into one that is nearly always treatable. Sawyers is also Leading a team that uses a new approach in finding a potential drug to attack cancer cells that have become resistant to enzalutamide (Xtandi), a targeted therapy for the treatment of advanced prostate cancer.

Charles L. Sawyers, MD, Chair, Human Oncology and Pathogenesis Program; Marie-Josee and Henry R. Kravis Chair, Memorial Sloan-Kettering Cancer Center, accepts the Giants of Cancer Care Award for his work in prostate cancer.

Sawyers says receiving the award was a complete surprise and he is both excited and honored to be in the company of the other recipients of the award.

Sawyers played a key role in the development of imatinib (Gleevec) and dasatinib (Sprycel), two drugs that together have transformed chronic myelogenous leukemia from a fatal cancer into one that is nearly always treatable. Sawyers is also Leading a team that uses a new approach in finding a potential drug to attack cancer cells that have become resistant to enzalutamide (Xtandi), a targeted therapy for the treatment of advanced prostate cancer.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x